INTERNATIONAL IMMUNOPHARMACOLOGY, cilt.3, ss.1257-1260, 2003 (SCI İndekslerine Giren Dergi)
Leukotriene receptor antagonists are being used widely in the treatment of bronchial asthma. They have been shown to possess anti-inflammatory properties, but there is no sufficient data about their effects on polymorphonuclear leukocyte functions.